Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users
Conditions: Methamphetamine Abuse; Methamphetamine-dependence; Addiction, Substance; Addiction Interventions: Drug: Treatment as Usual plus Placebo; Drug: Treatment as Usual plus Placebo plus Contingency Management; Drug: Treatment as Usual plus lisdexamfetamine (LDX-01); Drug: Treatment as Usual plus lisdexamfetamine (LDX-01) plus Contingency Management Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Canadian Institutes of Health Research (CIHR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials